Fresenius Kabi's Recall of Ketorolac Results In QuVa Pharma ® Recall of Compounded Sterile Product (R.E.C.K.)

QuVa Pharma, Inc. confirms that is working with the U.S. Food and Drug Administration, and voluntarily recalling all lots of R.E.C.K. (Ropivacaine, Epinephrine, Clonidine, Ketorolac) 50 ml in Sodium Chloride-60 ml BD syringe that were prepared using sterile Ketorolac being recalled by Fresenius Kabi

Source: FDA Center for Drug Evaluation and Research - What's New - April 27, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news